Skip to main content
. 2013 Feb 14;144(1):200–207. doi: 10.1378/chest.12-2431

Figure 3.

Figure 3.

Effect of camostat on maximal basal PD. A, B, Representative basal PD tracing of subjects treated with camostat 1.6 mg (A) and placebo (B). Predose and 2-h postdose tracings are shown for the same nostril and the same subject on the left and right sides of A and B, respectively. Maximal basal PD is designated with the gray bar. C, D, Maximal basal PD for each individual subject (●) and the mean of all subjects (○) treated with camostat 1.6 mg (C) and placebo (D). ***P < .005. Data are presented as mean ± SEM. AT = anterior tip of the inferior turbinate; PD = potential difference.